PB8 Stock Overview
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Phibro Animal Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$20.00 |
| 52 Week High | US$25.40 |
| 52 Week Low | US$11.00 |
| Beta | 0.58 |
| 1 Month Change | -7.41% |
| 3 Month Change | -2.91% |
| 1 Year Change | 81.82% |
| 3 Year Change | 11.73% |
| 5 Year Change | 10.50% |
| Change since IPO | -23.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| PB8 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 3.6% | -2.1% | -1.3% |
| 1Y | 81.8% | -14.9% | 13.1% |
Return vs Industry: PB8 exceeded the German Pharmaceuticals industry which returned -15.6% over the past year.
Return vs Market: PB8 exceeded the German Market which returned 13.3% over the past year.
Price Volatility
| PB8 volatility | |
|---|---|
| PB8 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in DE Market | 12.1% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: PB8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PB8's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 1,940 | Jack Bendheim | www.pahc.com |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Phibro Animal Health Corporation Fundamentals Summary
| PB8 fundamental statistics | |
|---|---|
| Market cap | €819.88m |
| Earnings (TTM) | €17.85m |
| Revenue (TTM) | €1.02b |
45.9x
P/E Ratio0.8x
P/S RatioIs PB8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PB8 income statement (TTM) | |
|---|---|
| Revenue | US$1.11b |
| Cost of Revenue | US$752.12m |
| Gross Profit | US$353.96m |
| Other Expenses | US$334.64m |
| Earnings | US$19.32m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.48 |
| Gross Margin | 32.00% |
| Net Profit Margin | 1.75% |
| Debt/Equity Ratio | 305.7% |
How did PB8 perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield101%
Payout RatioDoes PB8 pay a reliable dividends?
See PB8 dividend history and benchmarks| Phibro Animal Health dividend dates | |
|---|---|
| Ex Dividend Date | Mar 05 2025 |
| Dividend Pay Date | Mar 26 2025 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 2 days |
Does PB8 pay a reliable dividends?
See PB8 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/24 03:56 |
| End of Day Share Price | 2025/03/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Phibro Animal Health Corporation is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Balaji Prasad | Barclays |
| Matthew Korn | Barclays |
| Douglas Tsao | Barclays |